Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients

BACKGROUND: Thrombosis in COVID-19 worsens mortality. In our study, we sought to investigate how the dose and type of anticoagulation (AC) can influence patient outcomes. METHODS: This is a single-center retrospective analysis of critically ill intubated patients with COVID-19, comparing low-molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Volteas, Panagiotis, Drakos, Panagiotis, Alkadaa, Leor N., Cleri, Nathaniel A., Asencio, Anthony A., Oganov, Anthony, Giannopoulos, Stefanos, Saadon, Jordan R., Mikell, Charles B., Rubano, Jerry A., Labropoulos, Nicos, Tassiopoulos, Apostolos K., Mofakham, Sima, Bannazadeh, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc 2022
Materias:
Clinical Research Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212478/
https://www.ncbi.nlm.nih.gov/pubmed/35716998
http://dx.doi.org/10.1016/j.jvsv.2022.04.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212478/
https://www.ncbi.nlm.nih.gov/pubmed/35716998
http://dx.doi.org/10.1016/j.jvsv.2022.04.019

Ejemplares similares